Nanotechnological carriers for cancer chemotherapy: The state of the art

- Cancer is a group of malignant diseases, presenting great incidence and mortality in worldwide.
- Most current anticancer agents present lack of specificity, leading to systemic toxicity and adverse effects, limiting the maximum dose of drug.
- Nanocarriers for cytotoxic drugs have been explored, showing advantages which have allowed the clinical introduction.
- Nanocarriers could be considered as a multifunctional platform enable for personalized medicine.